SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-17-000876
Filing Date
2017-03-02
Accepted
2017-03-02 20:44:59
Documents
1
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 4 s105466_form4.html 4  
1 4 s105466_form4.xml 4 17367
  Complete submission text file 0001615774-17-000876.txt   19928
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures Fund VII, L.P. (Reporting) CIK: 0001509160 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 17661234

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0822
Vivo Ventures VII Affiliates Fund, L.P. (Reporting) CIK: 0001538309 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 17661233

Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 (650) 688-0822
VIVO VENTURES VII, LLC (Reporting) CIK: 0001565020 (see all company filings)

State of Incorp.: CA
Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 17661235